Location: Home
  • search
  • go
  • Relate News
  • 1/30/2022NHSA Issues the Interim Measures for Handling Tips Related to Supervis...
  • 1/30/2022Recent Executive Moves
  • 1/30/2022Financial-related Company News Digest
  • 1/29/2022NHSA Publicizes Scandal of Basic Medical Insurance Frauds Involving As...
  • 1/28/2022NHC Holds the 2022 National Health Working Conference
  • 1/28/2022NMPA Suspends Import, Sales and Use of JWLS's Fat Emulsion Product in ...
  • 1/27/2022CDE Issues the Guidelines for Clinical Trial Protocol Design for Once ...
  • 1/26/2022NMPA Announces Package Insert Revision of Numerous Drug Products
  • 1/26/202293 Listed MedPharm Cos Release 2021 Performance Guidance amid Weakness
  • 1/26/2022China Designates Shenzhen as Pilot Zone for Improved Market Access wit...
  • 1/26/2022Information Collection on the 7th VBP Initiated at Numerous Provinces
  • 1/25/2022Five Chinese Drug Companies to Make Merck's Covid-19 Pills for Poor Co...
  • 1/25/2022BPL Wins Chinese Approval to Market ALBUMINEX 25% in China
  • 1/25/2022CDE Issues the Technical Guidance on Clinical Protocol for Teriparatid...
  • 1/25/2022Protecting Pharmaceutical Trademarks in China and Taiwan
  • 1/24/2022Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdi...
  • 1/24/2022Amagma Therapeutics Announces Strategic Partnership with Innovent Biol...
  • 1/23/2022WuXi STA Opens Its First Parental Formulation Manufacturing Line
  • 1/21/2022Recent Executive Moves
  • 1/20/2022CDE Issues the Technical Guidance on Clinical Protocol for Injectable ...
  • 1/19/2022NMPA Solicits Comments on the Draft of GMP's Clinical Trial Drug Appen...
  • 1/19/2022NHSA Holds National Healthcare Security Conference, Highlighting Polic...
  • 1/19/2022Anti-tumor Drugs Became the Hottest Treatments in December (PharmaDJ's...
  • 1/18/2022NMPA Issues Two Registration Review Guidelines for Drug-Device Combina...
  • 1/18/2022Mabwell's IPO Debuts on SSE STAR Market, Shares Plunging 27%
  • 1/18/2022Review of Chinese Pharmaceutical industry Performance Q1/2019-Q3/2021
  • 1/17/2022What FDA Crackdown? Novartis Oncology Chief Touts BeiGene PD-1's Globa...
  • 1/17/2022China NMPA Novel Drug Approvals 2021 (PharmCube)
  • 1/17/2022Licensing Moves Towards Early-Stage Assets in 2021: PharmaDJ
  • 1/17/2022Massive Series A Rounds in December 2021 Highlight New R&D Trends: Pha...
  • Page:83/367 Total number of articles:10998: [First][<<] [81] [82] [83] [84] [85] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group